4th Quarter - Report

PODESTA GROUP, INC. for GENZYME

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

340B issues Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. S. 365 / Pub. L. 112-25, Budget Control Act of 2011.

Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis has an interest in the issues lobbied.

LobbyistCovered position, as disclosed
PAUL BRATHWAITE —
SHARON COHEN —
RANDALL GERARD —
LAUREN MADDOX —
ANTHONY PODESTA —
ANNE MARIE POLAK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2608 (112th), H.R. 3671 (112th), H.R. 2055 (112th), H.R. 3743 (112th), H.J.Res. 94 (112th), H.J.Res. 95 (112th), S. 365 (112th), H.R. 3765 (112th), H.R. 3630 (112th)

Medicare/Medicaid MMM

Medicare issues related to end stage renal disease. ASP changes. 340B issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. Medicare reimbursement issues.

Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis has an interest in the issues lobbied.

LobbyistCovered position, as disclosed
PAUL BRATHWAITE —
SHARON COHEN —
RANDALL GERARD —
LAUREN MADDOX —
ANTHONY PODESTA —
ANNE MARIE POLAK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.J.Res. 94 (112th), H.J.Res. 95 (112th), H.R. 3743 (112th), H.R. 3765 (112th), H.R. 3630 (112th), S. 365 (112th), H.R. 3671 (112th), H.R. 2055 (112th), H.R. 2608 (112th)

Budget/Appropriations BUD

FY 2012 budget appropriations. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.

Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis has an interest in the issues lobbied.

LobbyistCovered position, as disclosed
SHARON COHEN —
ANNE MARIE POLAK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.J.Res. 95 (112th), H.R. 2608 (112th), H.R. 3765 (112th), H.R. 3630 (112th), H.R. 2055 (112th), H.J.Res. 94 (112th), H.R. 3671 (112th), H.R. 2112 (112th), H.R. 3743 (112th)

Pharmacy PHA

Prescription Drug User Fee Act reauthorization. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). Product exclusivity issues.

Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis has an interest in the issues lobbied.

LobbyistCovered position, as disclosed
SHARON COHEN —
RANDALL GERARD —
LAUREN MADDOX —
ANNE MARIE POLAK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3671 (112th), H.J.Res. 95 (112th), H.R. 2112 (112th), H.J.Res. 94 (112th), S. 365 (112th), H.R. 2608 (112th), H.R. 3765 (112th), H.R. 3630 (112th), H.R. 3743 (112th), H.R. 2055 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.